SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-003345
Filing Date
2021-08-09
Accepted
2021-08-09 12:01:59
Documents
40
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sbfm_i10q-20210630.htm   iXBRL 10-Q 513979
2 CERTIFICATION sbfm_ex3101.htm EX-31.1 9957
3 CERTIFICATION sbfm_ex3102.htm EX-31.2 9950
4 CERTIFICATION sbfm_ex32.htm EX-32.1 4396
5 GRAPHIC image_001.jpg GRAPHIC 18672
6 GRAPHIC image_002.jpg GRAPHIC 21490
7 GRAPHIC image_003.jpg GRAPHIC 23519
8 GRAPHIC image_005.jpg GRAPHIC 9622
  Complete submission text file 0001683168-21-003345.txt   2722530

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sbfm-20210630.xsd EX-101.SCH 19136
10 XBRL CALCULATION FILE sbfm-20210630_cal.xml EX-101.CAL 37587
11 XBRL DEFINITION FILE sbfm-20210630_def.xml EX-101.DEF 56697
12 XBRL LABEL FILE sbfm-20210630_lab.xml EX-101.LAB 166597
13 XBRL PRESENTATION FILE sbfm-20210630_pre.xml EX-101.PRE 131667
14 EXTRACTED XBRL INSTANCE DOCUMENT sbfm_i10q-20210630_htm.xml XML 224269
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 211155552
SIC: 8731 Services-Commercial Physical & Biological Research